China Universal Asset Management »

Springworks Therapeutics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Springworks Therapeutics (SWTX) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Springworks Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Springworks Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Springworks Therapeutics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $458k 14k 32.04
2024-06-30 $328k 8.7k 37.67
2024-03-31 $699k 14k 49.22
2023-12-31 $264k 7.2k 36.50
2023-09-30 $37k 1.6k 23.12
2023-06-30 $22k 820 26.22
2023-03-31 $22k 847 25.74
2022-12-31 $17k 634 26.01
2022-09-30 $13k 463 28.08

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Springworks Therapeutics

Vanguard Group
BlackRock
BlackRock
Deep Track Capital
T. Rowe Price Associates
Boxer Capital
State Street Corporation
Maverick Capital
Marshall Wace
Pictet Asset Management Holding SA
Geode Capital Management
Arrowpoint Asset Management
OrbiMed Advisors
Woodline Partners
Siren

View all funds holding Springworks Therapeutics